Ignacio Martin-Loeches Selected Research

Ignacio Martin-Loeches Research Topics

Disease

54	Infections 01/2024 - 01/2009
42	Critical Illness (Critically Ill) 03/2024 - 01/2009
38	Ventilator-Associated Pneumonia 03/2024 - 01/2013
37	Sepsis (Septicemia) 02/2024 - 01/2013
36	COVID-19 03/2024 - 01/2020
33	Pneumonia (Pneumonitis) 12/2023 - 03/2009
22	Human Influenza (Influenza) 01/2022 - 01/2010
20	Respiratory Tract Infections (Respiratory Tract Infection) 01/2024 - 11/2015
18	Septic Shock (Toxic Shock Syndrome) 04/2023 - 04/2013
15	Healthcare-Associated Pneumonia 01/2024 - 08/2009
12	Communicable Diseases (Infectious Diseases) 03/2023 - 12/2016
11	Bacterial Pneumonia 01/2024 - 03/2009
9	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 05/2016
8	Cross Infection (Nosocomial Infection) 03/2024 - 09/2017
7	Respiratory Insufficiency (Respiratory Failure) 12/2023 - 10/2017
7	Shock 02/2023 - 03/2009
6	Inflammation (Inflammations) 01/2021 - 10/2018
4	Candidemia 01/2022 - 11/2018
4	Bacteremia 11/2021 - 05/2019
4	Virus Diseases (Viral Diseases) 03/2021 - 08/2011
3	Chronic Renal Insufficiency 10/2023 - 01/2021
3	Lung Injury 01/2023 - 03/2018
3	Wounds and Injuries (Trauma) 01/2023 - 04/2021
3	Superinfection 10/2022 - 11/2021
3	Coinfection 12/2020 - 02/2011
3	Viral Pneumonia 02/2014 - 05/2011
2	Intraabdominal Infections 01/2024 - 01/2016
2	Burns 11/2023 - 01/2021
2	Frailty 10/2023 - 03/2020
2	Aspergillosis 11/2022 - 01/2022
2	Invasive Pulmonary Aspergillosis 05/2022 - 10/2021
2	Neoplasms (Cancer) 04/2021 - 12/2018
2	Pulmonary Embolism 04/2021 - 01/2015
2	Acute Kidney Injury (Acute Renal Failure) 04/2021 - 03/2009
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 01/2015
2	Fatigue 01/2021 - 01/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2020 - 01/2020
2	Candidiasis (Moniliasis) 09/2019 - 05/2017
2	Brain Death (Brain Dead) 01/2019 - 01/2019
2	Obesity 03/2012 - 02/2011
1	Leukocytosis (Pleocytosis) 05/2024
1	Opportunistic Infections (Opportunistic Infection) 02/2024
1	Urinary Tract Infections (Urinary Tract Infection) 01/2024

Drug/Important Bio-Agent (IBA)

40	Anti-Bacterial Agents (Antibiotics)IBA 04/2023 - 03/2009
23	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2012
10	CytokinesIBA 01/2023 - 01/2009
8	Oxygen (Dioxygen)IBA 05/2024 - 02/2014
8	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 03/2012
6	SteroidsIBA 02/2024 - 12/2018
6	tazobactam drug combination ceftolozaneIBA 01/2024 - 12/2019
6	Antiviral Agents (Antivirals)IBA 09/2021 - 01/2011
6	Interleukin-6 (Interleukin 6)IBA 04/2021 - 01/2009
6	ProcalcitoninIBA 01/2021 - 05/2017
5	Meropenem (Merrem)FDA LinkGeneric 02/2023 - 12/2019
5	C-Reactive ProteinIBA 01/2021 - 05/2017
4	AntigensIBA 02/2023 - 01/2021
4	MacrolidesIBA 01/2023 - 09/2015
3	Proteins (Proteins, Gene)FDA Link 02/2023 - 01/2020
3	von Willebrand FactorIBA 10/2021 - 01/2021
3	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2015
3	LactamsIBA 04/2020 - 09/2015
3	Oseltamivir (Tamiflu)FDA Link 01/2020 - 05/2011
3	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 01/2013
3	Immunoglobulin A (IgA)IBA 01/2018 - 11/2013
2	Messenger RNA (mRNA)IBA 07/2023 - 03/2011
2	relebactamIBA 06/2023 - 04/2023
2	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 06/2023 - 04/2023
2	InterleukinsIBA 04/2023 - 01/2010
2	ThrombomodulinIBA 02/2023 - 10/2021
2	Third Generation CephalosporinsIBA 01/2023 - 04/2020
2	CatecholaminesIBA 01/2023 - 01/2023
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 01/2011
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023 - 01/2023
2	Thrombin FDA Link 10/2022 - 10/2021
2	carbapenemaseIBA 08/2022 - 10/2018
2	ceftolozaneIBA 01/2022 - 12/2020
2	Tazobactam FDA LinkGeneric 01/2022 - 12/2020
2	Fibrinogen (Factor I)FDA Link 11/2021 - 01/2021
2	Factor VIII (Coagulation Factor VIII)IBA 10/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 04/2021 - 10/2018
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2021 - 12/2015
2	GoldIBA 09/2020 - 01/2019
2	Antifungal AgentsIBA 09/2019 - 11/2018
2	Immunoglobulin G (IgG)IBA 01/2018 - 11/2013
1	PlasticsIBA 11/2023
1	omega-Chloroacetophenone (Mace)IBA 10/2023

Therapy/Procedure

53	Therapeutics 02/2024 - 03/2009
44	Artificial Respiration (Mechanical Ventilation) 03/2024 - 03/2009
39	Mechanical Ventilators (Ventilator) 01/2024 - 06/2014
35	Critical Care (Surgical Intensive Care) 02/2024 - 05/2014
11	Length of Stay 03/2022 - 08/2009
9	Resuscitation 01/2023 - 08/2014
4	Precision Medicine 12/2023 - 04/2017
4	Noninvasive Ventilation 01/2023 - 02/2014
3	Extracorporeal Membrane Oxygenation 04/2021 - 01/2018
3	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2021 - 12/2018
2	Duration of Therapy 01/2021 - 12/2020
2	Immunotherapy 12/2020 - 12/2019
2	Ambulatory Care (Outpatient Care) 01/2019 - 04/2016
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2018 - 03/2018